Clinical Trials in Switzerland / NCT07724145
Starting soon Observational

Association Between Female Hormonal Profile and Wound Healing

NCT07724145 · tracked via the Priya Life Science Switzerland tracker
Phase
Observational
Started
2026-07
Last updated
2026-07-23

Condition(s) studied

Wound HealingWound Healing ComplicationEstradiol

Study summary

The goal of this observational study is to assess the relationship between female hormonal status and postoperative wound healing in reduction mammaplasty. The main questions it aims to answer are:

1. Does wound healing differ depending on whether the operation takes place before or after ovulation in the menstrual cycle?
2. Does estradiol have a positive effect on wound healing?

Participants with mammary hypertrophy will undergo reduction mammaplasty, and the investigators will measure their hormonal profile (LH, FSH, and estradiol) on the day of surgery.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Symptomatic breast hypertrophy * Premenopausal Exclusion Criteria: * Previous breast reduction surgery * Menopausal status * Oral contraceptives * Corticosteroid therapy * History of breast cancer * Active smoking and use of nicotine substitution products

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Hospital of Geneva Geneva Switzerland

More University Hospital, Geneva trials in Switzerland

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07724145 on ClinicalTrials.gov ↗ ← All trials in Switzerland